Mayamin Tajbakhsh

Characterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapies

Natalia Liem, Rachael A. Papa, Christopher Milross et al. · Blood · 2004 · 239 citations · Full text

Medicine, Hematology, Oncology +12

The nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapse

Richard B. Lock, Natalia Liem, Monica L. Farnsworth et al. · Blood · 2002 · 205 citations

Medicine, Immunology, Oncology +14

Initial testing of the VEGFR inhibitor AZD2171 by the pediatric preclinical testing program

John M. Maris, Joshua Courtright, Peter J. Houghton et al. · Pediatric Blood & Cancer · 2007 · 117 citations

Medicine, Oncology, Pharmacology +17

Initial testing (stage 1) of sunitinib by the pediatric preclinical testing program

John M. Maris, Joshua Courtright, Peter J. Houghton et al. · Pediatric Blood & Cancer · 2008 · 85 citations · Full text

Medicine, Oncology, Pharmacology +10

Initial testing of dasatinib by the pediatric preclinical testing program

E. Anders Kolb, Richard Görlick, Peter J. Houghton et al. · Pediatric Blood & Cancer · 2007 · 74 citations

Medicine, Oncology, Pharmacology +13